Ftse Mib
33.436,07
0,33%
DAX
19.140,84
0,42%
S&P 500
5.916,98
0,40%
NASDAQ
18.987,47
1,04%
Bitcoin
93.615,38
1,38%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Danaher Corporation (DHR) Danaher Corporation (DHR) Notizie

Danaher Corporation

DHR
230,84
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:30:08
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/11/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202414:23EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
05/11/202422:01EDGAR2Form 144 - Report of proposed sale of securities
28/10/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202419:10EDGAR2Form 144 - Report of proposed sale of securities
22/10/202412:00PRNUSDanaher Reports Third Quarter 2024 Results
27/9/202414:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/9/202422:30PRNUSDanaher Schedules Third Quarter 2024 Earnings Conference..
17/9/202414:30PRNUSBeckman Coulter and Scopio Labs Add World's First Digital..
10/9/202422:15PRNUSDanaher Announces Quarterly Dividend
04/9/202422:30PRNUSDanaher Confirms Third Quarter and Full Year 2024 Guidance
26/8/202423:30PRNUSDanaher to Webcast Diagnostics Investor & Analyst Meeting in..
30/7/202413:30GLOBEBiogen, Beckman Coulter and Fujirebio to Collaborate on..
25/7/202415:00PRNUSBeckman Coulter's DxI 9000 Immunoassay Analyzer Honored at..
23/7/202412:00PRNUSDanaher Reports Second Quarter 2024 Results
17/7/202413:30PRNUSDanaher Announces Two New Centers of Innovation in..
16/7/202413:30PRNUSDanaher Releases 2024 Sustainability Report
11/7/202413:30PRNUSDanaher Launches Beacon Research Collaboration with Stanford..
09/7/202409:00PRNUSBeckman Coulter Introduces New Integrated Chemistry and..
24/6/202422:30PRNUSDanaher Schedules Second Quarter 2024 Earnings Conference..
19/6/202413:30PRNUSDanaher appoints Julie Sawyer Montgomery to Executive Vice..
05/6/202413:00PRNUSDanaher Appoints Martin Stumpe to New Role of Chief Data &..
09/5/202413:00PRNUSDanaher Launches Collaboration with Johns Hopkins University..
07/5/202422:45PRNUSDanaher to Present at Bank of America Securities Healthcare..
07/5/202422:15PRNUSDanaher Announces Quarterly Dividend
03/5/202415:06PRNUSCuriox Biosystems and Beckman Coulter Life Sciences Announce..
23/4/202412:00PRNUSDanaher Reports First Quarter 2024 Results
21/3/202421:15PRNUSDanaher Schedules First Quarter 2024 Earnings Conference..
27/2/202422:15PRNUSDanaher to Present at TD Cowen Health Care Conference
22/2/202422:15PRNUSDanaher Commits to Set Science-Based, Net-Zero Greenhouse..
21/2/202422:15PRNUSDanaher Announces Quarterly Dividend
05/2/202413:30PRNUSDanaher Launches Collaboration with Cincinnati Children's..
30/1/202412:00PRNUSDanaher Reports Fourth Quarter and Full Year 2023 Results
09/1/202413:30PRNUSDanaher, Jennifer Doudna, and Innovative Genomics Institute..
08/1/202422:57DJNDanaher Says 4Q Adjusted. Revenue to Fall by Less Than..
08/1/202422:15PRNUSDanaher CEO to Comment on Financial Performance
02/1/202423:00PRNUSDanaher to Present at J.P. Morgan Healthcare Conference
21/12/202322:30PRNUSDanaher Schedules Fourth Quarter 2023 Earnings Conference..
13/12/202322:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
06/12/202313:30PRNUSDanaher Completes Acquisition of Abcam
05/12/202323:14DJNDanaher Cuts Quarterly Dividend to 24 Cents
05/12/202322:30PRNUSDanaher Announces Quarterly Dividend
Apertura: Min: Max:
Chiusura: 230,84

La tua Cronologia

NYSE
DHR
Danaher
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network